JZYY(SH:600750)2017-04-19 16:00Financial Performance - Operating revenue declined by 10.71% to CNY 429,130,889.71 year-on-year[6] - Net profit attributable to shareholders increased by 1.55% to CNY 109,206,633.94[6] - Total operating revenue for Q1 2017 was CNY 331,991,320.42, a decrease of 17.3% compared to CNY 401,644,156.74 in the same period last year[34] - Net profit for Q1 2017 was CNY 101,433,921.84, down 8.4% from CNY 110,773,711.42 in Q1 2016[34] - Total comprehensive income for the period was CNY 109,251,683.94, compared to CNY 107,539,403.14 in the previous year, indicating a slight increase[32] Cash Flow - Cash flow from operating activities dropped significantly by 111.81% to -CNY 13,686,917.26 compared to the same period last year[6] - Net cash flow from operating activities was -13.69 million RMB, a decrease of 111.81% compared to the previous year, primarily due to a reduction in cash received from bank acceptance bills.[19] - The net cash flow from operating activities for the first quarter of 2017 was -22,011,723.76 RMB, a significant decrease compared to 115,752,612.95 RMB in the same period last year[41] - Total cash inflow from operating activities was 191,011,087.20 RMB, down 68.8% from 612,254,650.03 RMB year-over-year[41] - Cash outflow from operating activities totaled 213,022,810.96 RMB, a decrease of 57.1% compared to 496,502,037.08 RMB in the previous year[41] Assets and Liabilities - Total assets decreased by 1.87% to CNY 3,008,408,670.79 compared to the end of the previous year[6] - Current liabilities totaled 239.02 million RMB, down from 425.59 million RMB at the beginning of the year, indicating a significant reduction in short-term financial obligations.[24] - Total liabilities decreased to ¥194,261,981.85 in Q1 2017 from ¥260,480,664.00 at the start of the year, reflecting a reduction of 25.4%[28] - The company's cash and cash equivalents were ¥662,234,284.99 at the end of Q1 2017, down from ¥777,303,131.40 at the beginning of the year, a decline of 14.8%[26] - Inventory levels decreased to ¥128,497,982.25 in Q1 2017 from ¥171,326,454.82 at the beginning of the year, a reduction of 25.0%[26] Shareholder Information - The total number of shareholders reached 18,024 at the end of the reporting period[15] - The largest shareholder, Jiangxi Jiangzhong Pharmaceutical (Group) Co., Ltd., holds 43.03% of the shares[15] Expenses and Earnings - The gross margin for the pharmaceutical industry segment decreased by 5.38 percentage points to 68.51%[11] - Revenue from non-prescription drugs fell by 13.87% to CNY 369,943,673.48, with a gross margin decrease of 5.66 percentage points[11] - Revenue from the liquor segment surged by 358.67% to CNY 1,520,257.77, with a gross margin increase of 7.34 percentage points[11] - The company reported a significant reduction in selling expenses, which were ¥128,334,940.33 in Q1 2017, down 35.5% from ¥199,163,803.78 in Q1 2016[31] - Financial expenses improved, showing a gain of CNY 2,003,936.93 compared to a loss of CNY 76,489.50 in the same period last year[34] Investment Activities - Net cash flow from investing activities was -23.4 million RMB, a decrease of 33.03% year-on-year, mainly due to increased investment in the extraction of plant active ingredients and health food production projects.[19] - The net cash flow from investing activities was -22,161,963.65 RMB, worsening from -16,732,047.15 RMB in the same quarter last year[41] - Cash inflow from investing activities was 2,621,667.67 RMB, down 20.2% from 3,286,654.17 RMB year-over-year[41] - Cash outflow from investing activities increased to 24,783,631.32 RMB, up 23.4% from 20,018,701.32 RMB in the previous year[41] Other Financial Metrics - The company reported a basic earnings per share of CNY 0.36, unchanged from the previous year[6] - Basic and diluted earnings per share remained stable at CNY 0.36, unchanged from the previous year[34] - The company recorded an investment income of ¥42,889.17 in Q1 2017, compared to ¥1,518,438.96 in Q1 2016, indicating a significant decline in investment performance[31] - Investment income decreased to CNY 1,146,662.75 from CNY 2,359,809.79, reflecting a decline of 51.5%[34] - The company experienced a net decrease in cash and cash equivalents of 115,068,846.41 RMB during the quarter[42]